Northern Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.9M Sell
251,214
-69,298
-22% -$524K ﹤0.01% 3017
2025
Q1
$1.77M Sell
320,512
-66,864
-17% -$369K ﹤0.01% 2987
2024
Q4
$2.23M Sell
387,376
-149,329
-28% -$859K ﹤0.01% 2964
2024
Q3
$5.56M Sell
536,705
-308,411
-36% -$3.2M ﹤0.01% 2412
2024
Q2
$11M Sell
845,116
-88,240
-9% -$1.14M ﹤0.01% 1941
2024
Q1
$16.3M Sell
933,356
-2,137
-0.2% -$37.3K ﹤0.01% 1726
2023
Q4
$8.8M Sell
935,493
-24,413
-3% -$230K ﹤0.01% 2153
2023
Q3
$10.7M Sell
959,906
-14,871
-2% -$166K ﹤0.01% 1956
2023
Q2
$20.9M Buy
974,777
+111,461
+13% +$2.39M ﹤0.01% 1558
2023
Q1
$34.9M Sell
863,316
-19,814
-2% -$801K 0.01% 1186
2022
Q4
$41.1M Sell
883,130
-81,277
-8% -$3.78M 0.01% 1047
2022
Q3
$50M Buy
964,407
+33,116
+4% +$1.72M 0.01% 857
2022
Q2
$44M Buy
931,291
+3,198
+0.3% +$151K 0.01% 957
2022
Q1
$66.1M Sell
928,093
-84,071
-8% -$5.98M 0.01% 842
2021
Q4
$75.7M Buy
1,012,164
+53,116
+6% +$3.97M 0.01% 810
2021
Q3
$54.5M Buy
959,048
+310,246
+48% +$17.6M 0.01% 1013
2021
Q2
$28.6M Buy
648,802
+3,888
+0.6% +$171K 0.01% 1632
2021
Q1
$31.8M Buy
644,914
+407,185
+171% +$20.1M 0.01% 1489
2020
Q4
$10M Sell
237,729
-10,312
-4% -$434K ﹤0.01% 2247
2020
Q3
$11.4M Sell
248,041
-6,619
-3% -$303K ﹤0.01% 2042
2020
Q2
$12.8M Sell
254,660
-3,906
-2% -$196K ﹤0.01% 1951
2020
Q1
$13.3M Buy
258,566
+24,268
+10% +$1.25M ﹤0.01% 1697
2019
Q4
$14.5M Sell
234,298
-7,349
-3% -$454K ﹤0.01% 1945
2019
Q3
$14.5M Buy
241,647
+7,610
+3% +$457K ﹤0.01% 1910
2019
Q2
$19.7M Buy
234,037
+2,657
+1% +$224K ﹤0.01% 1704
2019
Q1
$22.1M Sell
231,380
-9,423
-4% -$900K 0.01% 1604
2018
Q4
$17.1M Buy
240,803
+9,207
+4% +$652K ﹤0.01% 1705
2018
Q3
$19.8M Buy
231,596
+7,653
+3% +$654K ﹤0.01% 1808
2018
Q2
$26M Buy
223,943
+32,113
+17% +$3.72M 0.01% 1562
2018
Q1
$15.5M Sell
191,830
-8,527
-4% -$690K ﹤0.01% 1882
2017
Q4
$11.8M Buy
200,357
+4,834
+2% +$284K ﹤0.01% 2081
2017
Q3
$9.15M Sell
195,523
-189
-0.1% -$8.85K ﹤0.01% 2257
2017
Q2
$7.04M Buy
195,712
+7,772
+4% +$280K ﹤0.01% 2403
2017
Q1
$5.79M Sell
187,940
-2,371
-1% -$73K ﹤0.01% 2463
2016
Q4
$6.38M Buy
190,311
+7,494
+4% +$251K ﹤0.01% 2386
2016
Q3
$4.86M Buy
182,817
+5,770
+3% +$154K ﹤0.01% 2539
2016
Q2
$3.9M Sell
177,047
-9,326
-5% -$206K ﹤0.01% 2630
2016
Q1
$5.48M Buy
186,373
+5,104
+3% +$150K ﹤0.01% 2354
2015
Q4
$5.99M Buy
181,269
+4,110
+2% +$136K ﹤0.01% 2356
2015
Q3
$6.4M Buy
177,159
+47,120
+36% +$1.7M ﹤0.01% 2296
2015
Q2
$5.85M Buy
130,039
+9,363
+8% +$421K ﹤0.01% 2424
2015
Q1
$3.7M Buy
120,676
+143
+0.1% +$4.38K ﹤0.01% 2701
2014
Q4
$6.13M Sell
120,533
-789
-0.7% -$40.1K ﹤0.01% 2370
2014
Q3
$4.8M Buy
121,322
+64,879
+115% +$2.57M ﹤0.01% 2534
2014
Q2
$2.43M Buy
56,443
+5,204
+10% +$224K ﹤0.01% 2975
2014
Q1
$2.05M Sell
51,239
-2,274
-4% -$90.9K ﹤0.01% 3124
2013
Q4
$1.46M Buy
53,513
+3,977
+8% +$109K ﹤0.01% 3276
2013
Q3
$1.14M Buy
49,536
+36,138
+270% +$828K ﹤0.01% 3302
2013
Q2
$237K Buy
+13,398
New +$237K ﹤0.01% 3626